2023
DOI: 10.1590/0037-8682-0513-2022
|View full text |Cite
|
Sign up to set email alerts
|

Monitoring fluoroquinolone resistance among ESBL-positive and ESBL-negative Escherichia coli strains isolated from urinary tract infections: An alert for empirical treatment

Abstract: Background: Bacterial resistance to extended-spectrum beta-lactamases (ESBL) is present worldwide. Empirical antibiotic therapy is often needed, and the use of fluoroquinolones, such as ciprofloxacin and norfloxacin, is common. This study aimed to analyze the urine cultures from 2,680 outpatients in January 2019, 2020, 2021, and 2022, with bacterial counts above 100,000 CFU/mL in which Escherichia coli was the etiological agent. Methods: We mo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 30 publications
(31 reference statements)
0
1
0
Order By: Relevance
“…On the other hand, their overuse has increased the resistance rate worldwide, especially among typical urologic pathogens like Escherichia Coli . 25,26…”
Section: Aims and Principles Of Antibiotic Prophylaxismentioning
confidence: 99%
“…On the other hand, their overuse has increased the resistance rate worldwide, especially among typical urologic pathogens like Escherichia Coli . 25,26…”
Section: Aims and Principles Of Antibiotic Prophylaxismentioning
confidence: 99%